This free -to-attend webinar series features industry leaders from Merck, Bristol Myers Squibb, Novo Nordisk, Alexion Pharmaceuticals, Mitsubishi Tanabe Pharma America, Inc, Sight Sciences, and Takeda as well as production partners discussing the latest trends, challenges and best practices in navigating the shifting life sciences meetings and events landscape. Key topics to be addressed include:

  • Elevating the meeting professional role to a strategic partner
  • Re-engineering your production partnerships to allow for optimal flexibility
  • Driving meaningful meeting experiences for virtual and in-person participants
  • Examining the latest compliance trends in a hybrid meeting environment
  • Advancing KPIs for virtual and hybrid events to provide impact data
  • Exploring the power of machine learning and AI to drive relevant content engagement

DAY 1 – 22 March 2022

Re-engineering Your Production Partnerships for Optimal Flexibility
12:00 pm EST / 4:00pm GMT / 5:00 pm CET

The meetings and events landscape continues to be volatile and unpredictable. Over the past four years, ADM Productions and Mitsubishi Tanabe Pharma America have forged a collaborative partnership to ensure that they have the capabilities necessary to turn an event on a dime if needed. This session examines the strategic approach to their successful partnership.

  • Examine the new reality of ensuring that all events have a scenario playbook of multiple contingency plans as wells as timelines of when to make the call to move forward with scenario A, B or C
  • Understand key criteria for creating a collaborative partnership with your production partner
  • Establish guidelines for keeping senior management in the loop to ensure that they have the information they need when a final go, no go or change format decision needs to take place
  • Discuss case examples and lessons learned


Dan Held
Vice President, New Business Development
ADM Productions

Sonya Easley, CMP, CMM, HMCC
Senior Manager, Meeting Planning & Field Coordination, Commercial
Mitsubishi Tanabe Pharma America, Inc.

View More Details +

Evolving the Meeting Professional Role in Life Sciences
1:00 pm EST / 5:00pm GMT / 6:00 pm CET

  • Understand how the growth of virtual and hybrid has impacted the meeting professional role
  • Assess the skillsets needed to thrive in the new meetings landscape
  • Review trends in outsourcing versus rebuilding internal teams
  • Consider forward for talent acquisition and talent management


James Vachon, CMM
Principal/Managing Partner
Michael Gerard and Associates


Jeffrey A. Cesari, CMP, HMCC
Associate Director
Bristol Myers Squibb

Stacy Wright, CMP, HMCC
Senior Manager, Meetings & Events
Sight Sciences

Janaye Taylor
Associate Director, Event Strategy & Operations
Alexion Pharmaceuticals

View More Details +

DAY 2 – 23 March 2022

Hybrid Meeting Design and Execution: Success Factors
12:00 pm EST / 4:00pm GMT / 5:00 pm CET

  • Review the scope of what comprises a “good” hybrid meeting
  • Discuss how to not to fall into the trap of designing two separate events for virtual and in-person audiences; understand the importance of merging the design process from the onset
  • Understand the power of machine learning and AI to drive relevant content engagement
  • Consider the impact and value of having the ability to sync experiences for in-person and virtual participants before, during and after the meeting
  • Examine case examples of hybrid meeting formats and features that yielded high marks from both virtual and in-person participants


Joe Schwinger

View More Details +

Driving Meaningful Meeting Experiences for Virtual and In-Person Participants
1:00 pm EST / 5:00pm GMT / 6:00 pm CET

  • Understand the unique meeting needs of virtual and in-person/hybrid participants
  • Discuss trends in creating opportunities for virtual and in-person participants to engage together
  • Review the latest engagement tools and strategies to exceed virtual and in-person audience members in hybrid meetings


Sonal Humane
Senior Director, Meeting Management

Michelle Shannon
Associate Director, Meetings Management
Novo Nordisk

Chris Bryant
Vice President, Analytics & Insights Management

View More Details +

DAY 3 – 24 March 2022

Assessing the Effectiveness of Virtual and Hybrid Events
12:00 pm EST / 4:00pm GMT / 5:00 pm CET

  • Discuss analytics and KPIs used to evaluate virtual events prior to the pandemic
  • Evolve KPIs and analytics to assess virtual and hybrid in the new meetings landscape
  • Examine best practices for using evaluation data to shift meeting design and execution for improved attendee experience.


Larissa Steinbäcker

Christian Holtz

Toby Frowen
Business Operations Consultant – Meetings + Events
ZS Associates

View More Details +

Compliance Trends and Updates in a Virtual/Hybrid Meeting Environment
1:00 pm EST / 5:00pm GMT / 6:00 pm CET

  • Understand the compliance landscape for virtual and hybrid meetings
  • Review PhRMA Code updates and implications for hybrid and virtual meetings


Angela Giovine, Manager
Meeting Program Management

Leighann T. Smedley, CMP, HMCC, PMP
Manager, HCP Meeting Execution and Compliance
Novo Nordisk

View More Details +

REGISTER NOW – Please select the webcast(s) you wish to attend and enter your contact details

Day 1

Day 2

Day 3